Kathrine Røe Redalen
Background and activities
I am Associate Professor at Department of Physics, NTNU, from 2017. I obtained my PhD from the University of Oslo in 2012 with research carried out at the Norwegian Radium Hospital.
Research
Research activities include functional cancer imaging (positron emission tomography (PET) and magnetic resonance imaging (MRI)), where we develop new acquisiton methods and image analysis approaches aimed at achieving a more precise cancer diagnosis, to retrieve predictive and prognostic information on treatment outcome and survival as well as improved evaluation of treatment efficacy during treatment. Further, we are using functional imaging to map the radiation sensitivity in individual tumours by utilising different approaches to quantitatively assess tumour oxygenation and vascular function, which are two important characteristics in the tumour microenvironment that affect both therapeutic response and disease outcome. Our imaging research is centred around applications in the field of radiotherapy, where we aim to improve the use of advanced imaging in radiation dose delivery and integrate PET and MRI information in modelling of both tumour response and normal tissue toxicity following radiation. We also have ongoing activity within functional MRI-based tumour segmentation approaches using machine learning.
More about research activities in the Medical Radiation Physics group.
Research projects
- CURIE - Cancer imaging by fUnctional magnetic resonance for Radiotherapy Individualisation and Evaluation, funded by the Norwegian Cancer Society, 2019 - 2023
- Improved diagnostics and treatment through a state-of-the-art multi-center nuclear medicine approach: Applications in cancer and dementia (180N - Norwegian Nuclear Medicine Consortium), funded by Trond Mohn Foundation, Central Norway Regional Health Authority, St. Olavs hospital and NTNU, 2019 - 2024
- Improved strategies for radiotherapy of prostate cancer utilizing proton therapy and advanced imaging modalities, funded by Central Norway Regional Health Authority, 2018 - 2023
- Development of Cu-64 radiopharmaceuticals for positron emission tomography (PET) and treatment of hypoxic, aggressive cancer, funded by Central Norway Regional Health Authority, 2019 - 2022
Research group members:
- Associate Professor II Signe Danielsen
- Associate Professor II Anne Beate L. Marthinsen
- Postdoc René Winter
- PhD candidate Franziska H. Knuth
- PhD candidate Kajsa M. L. Fridström
- PhD candidate Tengzhi Liu
- PhD candidate Guillermo Garrido Hernández
- MSc student Eline Furu Skjelbred
- MSc student Frida Marie Ihle Julbø
- MSc student Kaja Slåtsve Øvrelid
- MSc student Aase Mellingen Langan
Current teaching activities
Fall semester: TFY4225 - Radiation and Nuclear Physics
Spring semester: TFY4315 - Biophysics of Ionizing Radiation
Other
I am member of the Young Academy of Norway and the Young Committee/Physics Committee of the European Society for Radiotherapy and Oncology.
Scientific, academic and artistic work
Displaying a selection of activities. See all publications in the database
Journal publications
- (2020) Quantitative imaging for radiotherapy purposes. Radiotherapy and Oncology. vol. 146.
- (2020) Hypoxia imaging and theranostic potential of [64Cu][Cu(ATSM)] and ionic Cu(II) salts: a review of current evidence and discussion of the retention mechanisms. EJNMMI Research. vol. 10:33.
- (2019) High level of circulating vitamin D during neoadjuvant therapy may lower risk of metastatic progression in high-risk rectal cancer. BMC Cancer. vol. 19 (1).
- (2019) Immunogenic cell death by neoadjuvant oxaliplatin and radiation protects against metastatic failure in high-risk rectal cancer. Cancer Immunology and Immunotherapy.
- (2019) Comparison of Intravoxel incoherent motion imaging and multiecho dynamic contrast-based MRI in rectal cancer. Journal of Magnetic Resonance Imaging. vol. 50 (4).
- (2019) An experimental strategy unveiling exosomal microRNAs 486-5p, 181a-5p and 30d-5p from hypoxic tumour cells as circulating indicators of high-risk rectal cancer. Journal of Extracellular Vesicles. vol. 8 (1).
- (2019) Markers of mitochondrial metabolism in tumor hypoxia, systemic inflammation, and adverse outcome of rectal cancer. Translational Oncology. vol. 12 (1).
- (2019) Hva er fordelene med protonterapi sammenlignet med stråleterapi med fotoner, og hvorfor?. HMT - Helsetjenesten Medisinsk Teknikk : helse, medisin, teknikk. vol. 5.
- (2019) Sex-related differences in primary metastatic site in rectal cancer; associated with hemodynamic factors?. Clinical and Translational Radiation Oncology. vol. 21.
- (2019) Circulating Exosomal miR-141-3p and miR-375 in Metastatic Progression of Rectal Cancer. Translational Oncology. vol. 12 (8).
- (2018) Learning radiation oncology in Europe: Results of the ESTRO multidisciplinary survey. Clinical and Translational Radiation Oncology. vol. 9.
- (2018) Markers of mitochondrial metabolism in tumor hypoxia, systemic inflammation, and adverse outcome of rectal cancer. Translational Oncology. vol. 12 (1).
- (2018) Large-scale reduction of tyrosine kinase activities in human monocytes stimulated in vitro with N. meningitidis. PLOS ONE. vol. 13 (1).
- (2018) Systemic immune response induced by oxaliplatin-based neoadjuvant therapy favours survival without metastatic progression in high-risk rectal cancer. British Journal of Cancer. vol. 118 (10).
- (2017) Diffusion-weighted magnetic resonance imaging of rectal cancer: tumour volume and perfusion fraction predict chemoradiotherapy response and survival. Acta Oncologica. vol. 56 (6).
- (2017) Low release of exosomal miR-663a from hypoxic tumor cells and poor tumor response to neoadjuvant radiotherapy in rectal cancer patients. Cancer Research. vol. 77.
- (2017) Reactive oxygen species (ROS) and mitochondrial DNA (mtDNA) damage in tumor hypoxia, poor radiotherapy response, and metastatic progression of rectal cancer. Cancer Research. vol. 77.
- (2017) Use of non-invasive imaging to monitor response to aflibercept treatment in murine models of colorectal cancer liver metastases. Clinical and Experimental Metastasis. vol. 34 (1).
- (2017) Dynamic multi-echo DCE- and DSC-MRI in rectal cancer: Low primary tumor Ktrans and ΔR2* peak are significantly associated with lymph node metastasis. Journal of Magnetic Resonance Imaging. vol. 46 (1).
- (2017) Induction of Apoptosis in Intestinal Toxicity to a Histone Deacetylase Inhibitor in a Phase I Study with Pelvic Radiotherapy. Cancer research and treatment : official journal of Korean Cancer Association. vol. 49 (2).
- (2017) MR i strålebehandling – muligheter og utfordringer. HMT - Helsetjenesten Medisinsk Teknikk : helse, medisin, teknikk. vol. 5.
- (2016) Individual tumor volume responses to short-course oxaliplatin containing induction chemotherapy in locally advanced rectal cancer – Targeting the tumor for radiation sensitivity?. Radiotherapy and Oncology. vol. 119 (3).
- (2016) Systemic release of osteoprotegerin during oxaliplatin-containing induction chemotherapy and favorable systemic outcome of sequential radiotherapy in rectal cancer. OncoTarget. vol. 7 (23).
- (2016) Hypoxia regulates Notch-3 mRNA and receptor activation in prostate cancer cells. Heliyon. vol. 2 (5).
- (2016) High tumor glycine concentration is an adverse prognostic factor in locally advanced rectal cancer. Radiotherapy and Oncology. vol. 118 (2).
- (2016) Pro-survival responses to the dual inhibition of anti-apoptotic Bcl-2 family proteins and mTOR-mediated signaling in hypoxic colorectal carcinoma cells. BMC Cancer. vol. 16:531.
- (2015) Quantitative diffusion-weighted MRI of rectal cancer is strongly influenced by the choice of b-values. Radiotherapy and Oncology. vol. 115.
- (2015) Early increase in circulating carbonic anhydrase IX during neoadjuvant treatment predicts favourable outcome in locally advanced rectal cancer. BMC Cancer. vol. 15:543.
- (2015) Sulfamate inhibitor S4 influences carbonic anhydrase IX ectodomain shedding in colorectal carcinoma cells. Journal of enzyme inhibition and medicinal chemistry (Print). vol. 31 (5).
- (2015) Circulating proteins in response to combined-modality therapy in locally advanced rectal cancer identified by antibody array screening. Cancer Research. vol. 75 (15).
- (2015) High tumor PI3K signaling in resistance to chemoradiotherapy and metastatic dissemination of locally advanced rectal cancer. Molecular Cancer Therapeutics. vol. 14 (7).
- (2015) Tumor phosphatidylinositol 3-kinase signaling in therapy resistance and metastatic dissemination of rectal cancer: Opportunities for signaling-adapted therapies. Critical Reviews in Oncology/Hematology. vol. 95 (1).
- (2015) Personalized radiotherapy: concepts, biomarkers and trial design. British Journal of Radiology. vol. 88:20150009 (1051).
- (2015) Prediction of response to neoadjuvant chemotherapy followed by chemoradiotherapy in rectal cancer by MRI volumetry. Radiotherapy and Oncology. vol. 115.
- (2015) MRI volumetry for prediction of tumour response to neoadjuvant chemotherapy followed by chemoradiotherapy in locally advanced rectal cancer. British Journal of Radiology. vol. 88:20150097 (1051).
- (2014) On the role of experimental microenvironmental conditions in targeted inhibition of the pH-regulating carbonic anhydrase IX in colorectal carcinoma cells. Cancer Research. vol. 74.
- (2014) Molecular mechanisms of targeted drug toxicities in a clinical combined-modality radiotherapy study. Radiotherapy and Oncology. vol. 111.
- (2014) The Pelvic Radiation and Vorinostat (PRAVO) phase 1 study identifying MYC repression as biomarker of histone deacetylase inhibitor activity. Molecular Cancer Therapeutics. vol. 12.
- (2014) Biomarkers of histone deacetylase inhibitor activity in a phase 1 combined-modality study with radiotherapy. PLOS ONE. vol. 9 (2).
- (2014) Kinase activity in vemurafenib-sensitive and resistant BRAF-mutant melanoma cells. Molecular Cancer Therapeutics. vol. 12.
- (2014) Nye MR-teknikker for evaluering og prediksjon av respons på neoadjuvant behandling ved rektumcancer. Bestpractice Onkologi/Hematologi. vol. 16.
- (2013) Modifications in dynamic contrast-enhanced magnetic resonance imaging parameters after alpha-particle-emitting Th-227-trastuzumab therapy of HER2-expressing ovarian cancer xenografts. International Journal of Radiation Oncology, Biology, Physics. vol. 87 (1).
- (2013) Hypoxia-independent downregulation of hypoxia-inducible factor 1 targets by androgen deprivation therapy in prostate cancer. International Journal of Radiation Oncology, Biology, Physics. vol. 87 (4).
- (2013) Hypoxic tumor kinase signaling mediated by STAT5A in development of castration-resistant prostate cancer. PLOS ONE. vol. 8 (5).
- (2013) Differential inhibition of ex-vivo tumor kinase activity by vemurafenib in BRAF(V600E) and BRAF wild-type metastatic malignant melanoma. PLOS ONE. vol. 8 (8).
- (2012) ANDROGEN DEPRIVATION THERAPY PRIOR TO IRRADIATION OF PROSTATE CANCER: EXPRESSION OF HYPOXIA-INDUCED PROTEINS AND CHANGES IN DIFFUSION WEIGHTED MRI PARAMETERS. Radiotherapy and Oncology. vol. 102.
- (2012) DCEMRI IN ASSESSMENT OF TUMOR NEOVASCULARIZATION AFTER ANDROGEN-DEPRIVATION IN EXPERIMENTAL PROSTATE CANCER: CORRELATION TO QUANTITATIVE IMMUNOHISTOCHEMISTRY. Radiotherapy and Oncology. vol. 102.
- (2012) Vascular responses to radiotherapy and androgen-deprivation therapy in experimental prostate cancer. Radiation Oncology. vol. 7.
- (2011) Liposomal doxorubicin improves radiotherapy response in hypoxic prostate cancer xenografts. Radiation Oncology. vol. 6.
- (2011) Protein kinase activity and therapy response. European Journal of Cancer.
- (2011) Monitoring the Effect of Targeted Therapies in a Gastrointestinal Stromal Tumor Xenograft Using a Clinical PET/CT. Molecular Imaging and Biology. vol. 13 (6).
- (2011) Early prediction of response to radiotherapy and androgen-deprivation therapy in prostate cancer by repeated functional MRI: a preclinical study. Radiation Oncology. vol. 6.
- (2010) Radiotherapy and inhibition of the EGF family as treatment strategies for prostate cancer: combining theragnostics with theragates. Oncology Reviews. vol. 5 (2).
- (2010) Monitoring the Effect of Targeted Therapies in a Gastrointestinal Stromal Tumor Xenograft Using a Clinical PET/CT. Molecular Imaging and Biology.
- (2010) Preclinical dynamic F-18-FDG PET - tumor characterization and radiotherapy response assessment by kinetic compartment analysis. Acta Oncologica. vol. 49 (7).
- (2010) Prediction of response to cancer therapy from functional magnetic resonance image parameters - an artificial neural network approach. European Journal of Cancer. vol. 8 (5).
- (2010) Longitudinal magnetic resonance imaging-based assessment of vascular changes and radiation response in androgen-sensitive prostate carcinoma xenografts under androgen-exposed and androgen-deprived conditions. Neoplasia. vol. 12 (10).
- (2009) Establishment and Characterization of a Human Gastrointestinal Stromal Tumour (GIST) Xenograft in Athymic Nude Mice. Anticancer Research. vol. 29 (11).
- (2009) Artificial neural networks for prediction of response to chemoradiation in HT29 xenografts. International Journal of Radiation Oncology, Biology, Physics. vol. 75 (2).
- (2009) Artificial neural networks for prediction of response to chemoradiation in ht29 xenografts. International Journal of Radiation Oncology, Biology, Physics. vol. 75 (2).
- (2008) Dynamic contrast enhanced magnetic resonance imaging of bladder cancer and implications for biological image-adapted radiotherapy. Acta Oncologica. vol. 47 (7).
- (2008) Inhibitory effects of oxaliplatin in experimental radiation trestment of colorectal carcinoma : does oxiliplatin improve 5-fluorouracil-dependent radiosensivity?. Radiotherapy and Oncology. vol. 86.
- (2008) Principal component analysis for the comparison of metabolic profiles from human rectal cancer biopsies and colorectal xenografts using high–resolution magic angle spinning 1H magnetic resonance spectroscopy. Molecular Cancer. vol. 25 (7).
- (2007) Treatment response following combined capecitabine, oxaliplatin and radiation therapy monitored by diffusion weighted magnetic resonance imaging (DW-MRI) in a xenograft model. European Journal of Cancer Supplements. vol. 5 (4).
- (2007) Early changes in apparent diffusion coefficient predict the quantitative antitumoral activity of capecitabene, oxaliplatin, and irradiation in HT29 xenografts in athymic nude mice. Neoplasia. vol. 9 (5).
- (2007) Construction of a modified capacitive overlap MR coil for imaging of small animals and objects in a clinical whole-body scanner. Physics in Medicine and Biology. vol. 52.
- (2007) Noninvasive monitoring of radiation-induced treatment respons using proton magnetic resonance spectroscopy and diffusion-weighted magnetic resonance imaging in a colorectal tumor model. Radiotherapy and Oncology. vol. 85.
Others
- (2019) Fra ukjent til å bli på hils med statsråden. Universitetsavisa [Avis]. 2019-10-18.
- (2019) MRI of Extramural Venous Invasion in rectal cancer: assessment of the interobserver agreement and comparison with histopathology stained with hematoxylin/eosin and elastin. European Congress for Gastrointestinal and Abdominal Radiology . European Society for Gastroinestinal and Abdominal Radiolog); Roma. 2019-06-04 - 2019-06-08.
- (2019) Automatic tumor delineation in rectal cancer using functional MRI and machine learning. MedFys 2019 . Norsk Forening for Medisinisk Fysikk; Kvitfjell. 2019-02-04 - 2019-02-06.
- (2019) Automatic tumour delineation in rectal cancer using functional MRI and machine learning. ESTRO 38 . European Society for Radiotherapy and Oncology; Milan. 2019-04-26 - 2019-04-30.
- (2019) Functional MR-based automatic tumor segmentation of rectal cancer. BiGART2019 - 18th Acta Oncologica conference ; Aarhus. 2019-05-22 - 2019-05-24.
- (2019) Gender disparities in outcome after neoadjuvant chemoradiotherapy for locally advanced rectal cancer are associated with hemodynamic differences. ESTRO 38 . European Society for Radiation Oncology; Milano. 2019-04-26 - 2019-04-30.
- (2019) Circulating angiogenic factors predict metastatic liver progression in rectal cancer patients given curative-intent oxaliplatin-containing neoadjuvant therapy. American Association for Cancer Research Annual Meeting . American Association for Cancer Research; Atlanta, Georgia. 2019-03-29 - 2019-04-03.
- (2019) Funksjonell MR; verktøy for prediksjon av behandlingseffekt ved rektumcancer. Multidisiplinært onkologisk GI-cancer møte . Amgen og Bayer; Trondheim. 2019-02-07 - 2019-02-08.
- (2019) Imaging biomarkers. MED3062 – Påvisning og monitorering av sykdom i laboratoriet . Universitetet i Oslo; Akershus universitetssykehus. 2019-01-21 - 2019-02-01.
- (2019) Kan bedre bildediagnostikk gjøre kreftbehandlingen enda bedre?. Temakafé for kreftpasienter og pårørende . Kreftforeningen; Steinkjer. 2019-09-25 - 2019-09-25.
- (2019) MRI-based dose-painting of rectal cancer. 34th Conference on Clinical and Experimental Research in Radiation Oncology (CERRO) . ESTRO (European Society for Radiotherapy and Oncology); Le Menuires. 2019-01-19 - 2019-01-26.
- (2019) Maskinlæring i stråleterapi. Norsk stråleterapimøte . Norsk forening for medisinsk fysikk; Oslo. 2019-09-19 - 2019-09-20.
- (2019) What characterizes a good relationship between a supervisor and a student?. TEKNA seminar - Academic supervision . TEKNA; Litteraturhuset, Trondheim. 2019-03-07 - 2019-03-07.
- (2018) Predicting tumour response to chemoradiotherapy in rectal cancer using dynamic contrast enhanced MRI. European Society for Radiotherapy and Oncology (ESTRO) 37th annual meeting . ESTRO (European Society for Radiotherapy and Oncology); Barcelona. 2018-04-20 - 2018-04-24.
- (2018) Comparison of Apparent Diffusion Coefficients from Diffusion-Weighted Imaging of Rectal Cancer at different MR scanners. European Congress of Radiology 2018 . European Society of Radiology; Wien. 2018-02-28 - 2018-03-02.
- (2018) Baseline dynamic R2* MRI in rectal cancer is associated with chemoradiotherapy outcome. 6th MR in RT symposium ; Utrecht. 2018-06-30 - 2018-07-03.
- (2018) Biomarker discovery. 2nd ESTRO Physics workshop . ESTRO (European Society for Radiotherapy and Oncology); Malaga. 2018-10-26 - 2018-10-27.
- (2018) Bruk av MR for utredning og behandling av kreft med spesielt henblikk på colorectal og prostata. Seminar Kreftklinikken, St. Olavs hospital ; 2018-04-05 - 2018-04-05.
- (2018) MRI in radiotherapy. MRI in radiotherapy . Kreftklinikken, St. Olavs hospital og Inst. for fysikk, NTNU; Trondheim. 2018-12-05 - 2018-12-05.
- (2018) Motivasjonsforedrag. Fakultet for naturvitenskap sin velkomstdag for jenter . Fakultet for naturvitenskap; Trondheim. 2018-08-12 - 2018-08-12.
- (2018) Prediction of chemoradiotherapy response in rectal cancer using static and dynamic R2* MRI. European Society for Radiotherapy and Oncology (ESTRO) 37th annual meeting . ESTRO (European Society for Radiotherapy and Oncology); Barcelona. 2018-04-20 - 2018-04-24.
- (2017) Diffusion-weighted MRI of rectal cancer: baseline tumour perfusion fraction predicts chemoradiotherapy response and survival. International Society for Magnetic Resonance in Medicine 25th Annual Meeting . International Society for Magnetic Resonance in Medicine; Hawaii. 2017-04-22 - 2017-04-27.
- (2017) Mechanisms of normal tissue toxicity from SAHA - an HDAC inhibitor and radiosensitizer. ESTRO 36 - Annual Meeting of the European Society for Radiotherapy & Oncology . European Society for Radiotherapy & Oncology; Wien. 2017-05-05 - 2017-05-09.
- (2017) Improved sensitivity for rectal cancer differentiation by T2*-correction in DCE-MRI. International Society for Magnetic Resonance in Medicine 25th Annual Meeting . International Society for Magnetic Resonance in Medicine; Hawaii. 2017-04-22 - 2017-04-27.
- (2017) Circulating angiogenesis factors predicting poor chemoradiotherapy outcome in rectal cancer. ESTRO 36 - Annual Meeting of the European Society for Radiotherapy & Oncology . European Society for Radiotherapy & Oncology; Wien. 2017-05-05 - 2017-05-09.
- (2017) Circulating exosomal miRNA related to chemoradiotherapy outcome in locally advanced rectal cancer. ESTRO 36 - Annual Meeting of the European Society for Radiotherapy & Oncology . European Society for Radiotherapy & Oncology; Wien. 2017-05-05 - 2017-05-09.
- (2017) Extracellular vesicles in radiation oncology. ESTRO 36 - Annual Meeting of the European Society for Radiotherapy & Oncology . European Society for Radiotherapy & Oncology; Wien. 2017-05-05 - 2017-05-09.
- (2017) Functional MRI in metastatic colorectal cancer. Regional Research Network Acredit - Advanced Colorectal Cancer Individualization of Therapies ; 2017-11-02 - 2017-11-03.
- (2017) Tok sjansen, fikk gjennombrudd mot kreft. Forskerforum [Fagblad]. 2017-04-03.
- (2017) Vi har et kjempeproblem hvis skepsisen til oss øker. Universitetsavisa [Avis]. 2017-09-25.
- (2017) OxyTarget-studien i rectumcancer - sammenhenger mellom funksjonelle MR-data, lymfeknuter, sirkulerende markører og fjernmetastaser. Kirurgisk forskningsforum ; 2017-01-12 - 2017-01-12.
- (2016) Tumour perfusion estimated from diffusion-weighted MRI of rectal cancer – an indirect marker of tumour hypoxia?. The 8th National PhD Conference in Medical Imaging . Norwegian Research School in Medical Imaging; Trondheim. 2016-11-21 - 2016-11-22.
- (2016) Histogram analysis of ADCs from DWMRI predicts tumour response and survival for rectal cancer. 35th annual meeting of the European Society for Radiotherapy & Oncology (ESTRO) ; Torino. 2016-04-29 - 2016-05-03.
- (2016) Exosomes from hypoxic colorectal cancer cells – miRNA cargo as indicator of adverse CRC biology?. The fifth international meeting of the International Society of Extracellular Vesicles . ISEV; Rotterdam. 2016-05-04 - 2016-05-07.
- (2016) Diffusion-weighted MRI can predict response to aflibercept in in vivo models. American Association for Cancer Research (AACR) Annual Meeting . AACR; New Orleans. 2016-04-16 - 2016-04-20.
- (2016) Oxaliplatin-induced immune factors and long-term disease control in rectal cancer - a reflection of immunogenic tumor cell death?. AACR Annual Meeting 2016 . American Association for Cancer Research; New Orleans. 2016-04-16 - 2016-04-20.
- (2016) Bildediagnostikk og strålebehandling av kreft. Institutt for Energiteknikk (IFE) samarbeidsmøte . Institutt for Energiteknikk (IFE); Kjeller. 2016-02-29 - 2016-02-29.
- (2016) Forskernatt i akademiet. forskning.no [Internett]. 2016-08-16.
- (2016) Kreftforeningen må ta bedre vare på unge forskere. forskning.no [Internett]. 2016-05-05.
- (2016) Measures of diagnostic accuracy – basic definitions and ROC-analysis. End-points and statistics in biomarker studies and clinical trials . Regional Research Network ACREDIT; Oslo. 2016-05-19 - 2016-05-19.
- (2016) Medical imaging in cancer biology and personalized therapy. Oslo University Hospital Research Seminar . Kathrine Røe Redalen; Rikshospitalet, Oslo. 2016-01-11 - 2016-01-11.
- (2016) High tumour glycine concentration – an adverse prognostic factor in locally advanced rectal cancer. 35th annual meeting of the European Society for Radiotherapy & Oncology (ESTRO) ; Torino. 2016-04-29 - 2016-05-03.
- (2015) Histogram analysis of apparent diffusion coefficients from diffusion-weighted MRI during neoadjuvant treatment of locally advanced rectal cancer predicts histologic tumor response and survival. The 7th National PhD Conference in Medical Imaging . Norwegian Research School in Medical Imaging; Oslo. 2015-11-16 - 2015-11-17.
- (2015) Histone deacetylase inhibitors in combined-modality cancer treatment – experimental studies of normal tissue effects. Frampeik - Medisinstudentenes Forskningskonferanse ; Tromsø. 2015-10-30 - 2015-11-01.
- (2015) Feasibility of multi-echo dynamic MRI for simultaneous acquisition of T1-weighted and R2* contrast kinetics in rectal cancer. Biology-Guided Adaptive Radiotherapy, 13th Acta Oncologica symposium ; Århus. 2015-06-10 - 2015-06-12.
- (2015) Circulating osteoprotegerin as inflammatory mediator of toxicity and survival to combined-modality therapy in rectal cancer. European Cancer Congress 2015 . ECCO, ESMO, ESTRO, ESSO, EACR, EONS and SIOPE; Vienna. 2015-09-25 - 2015-09-29.
- (2015) Circulating tumor necrosis factor receptor (TNFR) proteins in systemic disease outcome to combined-modality radiotherapy in rectal cancer. International Conference on Molecular Targets and Cancer Therapeutics . American Association for Cancer Research; Boston, Massachusetts. 2015-11-05 - 2015-11-09.
- (2015) The OxyTarget study – Functional MRI of Hypoxia-Mediated Rectal Cancer Aggressiveness. The 7th National PhD Conference in Medical Imaging . Norwegian Research School in Medical Imaging; Oslo. 2015-11-16 - 2015-11-17.
- (2015) Ny dynamisk MR-sekvens for bedre karakterisering av endetarmskreft. Høstmøtet 2015 . Norsk Radiologisk Forening, Norsk Forening for Med. Fysikk; Oslo. 2015-10-20 - 2015-10-23.
- (2015) Vil lage mer tilpasset behandling for endetarmskreft. forskning.no [Internett]. 2015-10-06.
- (2015) Identification of optimal culturing conditions for studying exosomes from normoxic and hypoxic colorectal cancer cell lines. 4th international meeting of International Society for Extracellular Vesicles (ISEV) ; 2015-04-23 - 2015-04-26.
- (2014) Crohns disease and secondary malignancy: Morphological findings with MRI and CT and how novel functional MR sequences can improve diagnostics. RSNA, Annual meeting . Radiological society of North America; Chicago. 2014-11-30 - 2014-12-05.
- (2014) Individualisert behandling av tarmkreft. Akershus universitetssykehus åpen kveld om forskning ; 2014-04-01 - 2014-04-01.
- (2014) OxyTarget study - Functional MRI of hypoxia-mediated rectal cancer aggressiveness. Kick-off meeting Regional Research Network ACREDIT - Advanced ColoRectal Cancer - Individualization of Therapies . Regional Research Network ACREDIT - Advanced ColoRectal Can; Oslo. 2014-10-08 - 2014-10-08.
- (2014) Spredning av kreft via mikroblærer. Kreftforeningen [Internett]. 2014-01-09.
- (2012) Tyrosine kinase activity profiling of metastatic malignant melanoma: Identification of possible therapeutic targets and markers predicting response to therapy. American Association of Cancer Research ; Chicago, IL. 2012-03-31 - 2012-04-04.
- (2010) Quantitative in vivo DCE MRI of prostate cancer xenografts: assessment of ADT and RT efficacy. Molecular Imaging in Radiation Oncology (MIRO) ; Brussels. 2010-03-18 - 2010-03-20.
- (2010) Early prediction of treatment response in xenografts using quantitative diffusion weighted MRI. Molecular Imaging in Radiation Oncology (MIRO) ; Brussels. 2010-03-18 - 2010-03-20.
- (2007) Treatment response following combined capecitabine, oxaliplatin and radiation therapy monitored by diffusion weighted magnetic resonance imaging (DW-MRI) in a xenograft model. 14th European Cancer Conference (ECCO 14 . European Cancer Organization; Barcelona. 2007-09-23 - 2007-09-27.